WP
Woodline Partners Portfolio holdings
AUM
$18.9B
1-Year Return
23.37%
This Quarter Return
+13.42%
1 Year Return
+23.37%
3 Year Return
+125.78%
5 Year Return
+185.63%
10 Year Return
–
AUM
$10.8B
AUM Growth
+$1.65B
(+18%)
Cap. Flow
+$863M
Cap. Flow
% of AUM
7.98%
Top 10 Holdings %
Top 10 Hldgs %
14.33%
Holding
675
New
211
Increased
170
Reduced
126
Closed
150
Top Buys
| 1 |
ERF
Enerplus Corporation
ERF
|
$110M |
| 2 |
TE Connectivity
TEL
|
$84.6M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
$78.6M |
| 4 |
Honeywell
HON
|
$72.8M |
| 5 |
Palo Alto Networks
PANW
|
$71.1M |
Top Sells
| 1 |
AbbVie
ABBV
|
$116M |
| 2 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$113M |
| 3 |
INBX
Inhibrx, Inc. Common Stock
INBX
|
$88.1M |
| 4 |
Permian Resources
PR
|
$75M |
| 5 |
SPLK
Splunk Inc
SPLK
|
$70.1M |
Sector Composition
| 1 | Healthcare | 38.65% |
| 2 | Technology | 22.91% |
| 3 | Industrials | 9.85% |
| 4 | Energy | 8.37% |
| 5 | Consumer Discretionary | 7.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RCM
301
DELISTED
R1 RCM Inc. Common Stock
RCM
| $7.86M | 0.07% |
+610,222
| New | +$7.86M |
|
302
Masimo
MASI
$8B
| $7.8M | 0.07% |
53,146
-229,129
| -81% | -$33.6M |
|
303
Spectrum Brands
SPB
$1.38B
| $7.72M | 0.07% |
+86,746
| New | +$7.72M |
|
304
Structure Therapeutics
GPCR
$1.27B
| $7.71M | 0.07% |
179,892
+673
| +0.4% | +$28.8K |
|
305
Viridian Therapeutics
VRDN
$1.53B
| $7.69M | 0.07% |
+438,922
| New | +$7.69M |
|
306
Broadcom
AVGO
$1.58T
| $7.68M | 0.07% |
+57,920
| New | +$7.68M |
|
|
EGLE
307
DELISTED
Eagle Bulk Shipping Inc.
EGLE
| $7.63M | 0.07% |
122,096
+104,076
| +578% | +$6.5M |
|
308
International Flavors & Fragrances
IFF
$16.9B
| $7.63M | 0.07% |
88,685
-98,777
| -53% | -$8.49M |
|
309
Flowserve
FLS
$7.22B
| $7.62M | 0.07% |
166,921
+120,865
| +262% | +$5.52M |
|
310
Rhythm Pharmaceuticals
RYTM
$6.78B
| $7.46M | 0.07% |
172,207
+97,357
| +130% | +$4.22M |
|
311
Edgewise Therapeutics
EWTX
$1.64B
| $7.39M | 0.07% |
405,132
+920
| +0.2% | +$16.8K |
|
312
Western Digital
WDC
$31.9B
| $7.34M | 0.07% |
142,242
-1,022,678
| -88% | -$52.7M |
|
313
Tencent Music
TME
$37.7B
| $7.29M | 0.07% |
651,308
+47,434
| +8% | +$531K |
|
314
US Physical Therapy
USPH
$1.3B
| $7.28M | 0.07% |
+64,540
| New | +$7.28M |
|
315
Arcellx
ACLX
$4.03B
| $7.24M | 0.07% |
104,060
| – | – |
|
316
Crinetics Pharmaceuticals
CRNX
$3.35B
| $7.18M | 0.07% |
153,395
+3,395
| +2% | +$159K |
|
317
GitLab
GTLB
$7.63B
| $7.12M | 0.07% |
+122,048
| New | +$7.12M |
|
318
Procter & Gamble
PG
$375B
| $7.11M | 0.07% |
+43,799
| New | +$7.11M |
|
319
Enliven Therapeutics
ELVN
$1.19B
| $6.96M | 0.06% |
395,686
| – | – |
|
320
Biomea Fusion
BMEA
$114M
| $6.95M | 0.06% |
464,573
| – | – |
|
321
American International
AIG
$43.9B
| $6.93M | 0.06% |
+88,640
| New | +$6.93M |
|
|
VERV
322
DELISTED
Verve Therapeutics
VERV
| $6.92M | 0.06% |
521,112
+23
| +0% | +$305 |
|
|
SLRN
323
DELISTED
ACELYRIN
SLRN
| $6.89M | 0.06% |
1,021,204
+72,645
| +8% | +$490K |
|
324
GE HealthCare
GEHC
$34.6B
| $6.82M | 0.06% |
+75,000
| New | +$6.82M |
|
|
INZY
325
DELISTED
Inozyme Pharma
INZY
| $6.8M | 0.06% |
888,067
+588,067
| +196% | +$4.5M |
|